Founded in 2004, NIBEC Co Ltd is a South Korean company focused on research and development of drug and biomaterial-based medical devices. They offer a range of products, including peptide-based bio fusion and various other solutions for bone grafts, tissue regeneration, and drug delivery. NIBEC's key technology is a target cell penetrating peptide based drug delivery platform, which they collaborate on globally. They are also involved in cosmetic production and sales.